American Association for Cancer Research

The American Association for Cancer Research (AACR) aims to stop cancer and find cures by focusing on research, education, communication, and teamwork. The AACR supports research in cancer and related fields, helps share new findings quickly among scientists and those committed to fighting cancer, encourages science education and training, and works to improve knowledge about cancer causes, prevention, diagnosis, and treatment globally.

National

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#193981

United States

#69371

Health/Health Conditions and Concerns

#159

Traffic sources

Monthly visitors

Articles

What Are the Benefits of Exercise for Cancer Patients?

1 week ago | aacr.org | Andrew Matthius

While most individuals, including cancer patients, understand that exercise is good for overall health, several recent studies have highlighted just how much of an impact physical activity can have on survival and quality of life for patients with cancer. Associations between exercise and benefits to cancer patients have long been studied.
The Impact of Funding Cuts: AACR Annual Meeting 2025 Shows Why Cancer Research Matters

1 month ago | aacr.org | Andrew Matthius

One of the resounding messages to emerge from the AACR Annual Meeting 2025, held April 25-30, was how cancer research is at a crossroads unlike anything researchers have seen before amid funding cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Presidential Symposium Showcases Global Researchers Tackling Cancer Burden

1 month ago | aacr.org | Andrew Matthius

About 1 in 5 people currently develop cancer in their lifetime. By 2050, the global incidence of cancer is expected to increase from 20 million cases each year to over 35 million. These projections are one of the reasons Patricia M. LoRusso, DO, PhD(h), FAACR, made global health a key initiative of her tenure as President of the American Association for Cancer Research (AACR). “Cancer is a global disease—it spares no continent, no country,” LoRusso, of Yale University, said during the meeting.
AACR Annual Meeting 2025: What’s Next for the AACR 2025 NextGen Stars?

2 months ago | aacr.org | Andrew Matthius

How can we better map the evolution of cancer to help improve precision therapy? What role does age play in the development of cancer? What can be learned from tissues that rarely get cancer? What understudied targets are worth studying? These are among the questions that fascinate the early-career researchers selected as the 2025 NextGen Stars by the American Association for Cancer Research (AACR).
Senate Forum Examined the Ramifications of NIH Funding Cuts

2 months ago | aacr.org | Andrew Matthius

Originally founded in 1887, the National Institutes of Health (NIH) has not only become a key component of medical research in the United States, but one of the foremost research centers in the world. Between 2010 and 2019, 354 out of the 356 therapeutics approved by the U.S. Food and Drug Administration (FDA) involved research that was at least in part funded by the NIH.
Cancer Today’s Spring 2025 Issue: How Liquid Biopsies Can Guide Treatment Decisions, Extending Survival in Treatment-resistant Breast Cancer, and More

Mar 20, 2025 | aacr.org | Thomas Celona

After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but he would have to wait four to six weeks for results from tumor tissue testing. The possibility of targeted therapy sounded promising, but the wait did not. “When you get diagnosed with cancer, it’s like, get me on some kind of treatment,” Schumpert says.
Meet The CheckPoints: A Band of Researchers and Oncologists Giving Cancer Treble

Mar 17, 2025 | aacr.org | Andrew Matthius

If Eddie and Alex Van Halen hadn’t asked David Lee Roth to join their band so they wouldn’t have to keep renting his PA system, would we have Van Halen? If Larry Mullen, Jr., never posted a note on his high school bulletin board looking for band members, would he have ever met Paul Hewson (Bono), David Evans (The Edge), and Adam Clayton and formed U2? If Roger Waters and Nick Mason weren’t both studying architecture in London, would we have Pink Floyd?
AACR Patient Advocate Forum: Patient-centric Cancer Clinical Trial Design

Feb 6, 2025 | aacr.org | Eric Fitzsimmons

Before a new treatment becomes available for cancer patients, it must be tested in clinical trials and shown to be both safe for use and effective at treating the disease. But an explosion of new approaches to care, the rise of precision oncology that targets certain tumor mutations rather than broad cancer types, and low rates of clinical trial participation leave researchers asking if there are enough clinical trial participants to keep cancer research moving forward.
Faith and Ingenuity: Bringing the First Oncology Clinical Trial to Trinidad

Jan 16, 2025 | aacr.org | Andrew Matthius |Emma Quinn

Faithanne Hill is not your typical Trinidadian. For one, she loves the beach, which may sound obvious considering she lives on an island, but that is not the case for everyone in Trinidad. “The beach is always there—it never goes away—so most people only go on special occasions or when there’s a holiday,” explained Faith (as she likes to be called). “But I make it a point of going.
Clinical Trials Are Testing Ways to Prevent Breast Cancer | Blog | AACR

Jan 15, 2025 | aacr.org | Neha J. Pancholi

At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent breast cancer.